NCT01162668

Brief Summary

Objective: to assess the health and economic outcomes (weight lost, change in control of chronic diseases such as diabetes, quality of life, work productivity, health care cost, etc) associated with bariatric (weight-loss) surgery for 200 severely obese patients who undergo bariatric surgery as part of the Mississippi State Employees' Life and Health Insurance Plan's Obesity Treatment Program (OTP). 2\. Patient Characteristics: Inclusion criteria: Eligible bariatric surgical candidates who are enrolled in the OTP (100 patients per year for 2 years). The Plan's criteria includes, but is not limited to 1) enrollment in the plan for at least 12 consecutive months prior to September 1, 2009; 2) completion of the HealthQuotient health risk assessment through the Plan's wellness and health promotion program; 3) a Body Mass Index (BMI) of \>40 kg/m2, or a BMI \>35 kg/m2 with two or more co-morbidities such as diabetes, hypertension, sleep apnea or asthma; 4) two or more physician-supervised weight loss attempts within the last 24 months; 5) age 18 years or older; and 6) consent to provide personal and medical information to the Plan. Prior to surgery, each site administers a psychiatric evaluation to ensure the patient is psychologically stable for surgery. Exclusion criteria: any patient who does not meet criteria above or who declines to participate. Surgeries will take place only at Certified Bariatric Surgery Centers of Excellence (COE), of which, there are currently 3 in the state. The 3 COEs exist with 4 outpatient medical offices (1 COE is composed of 2 independent surgeon practices) Patients will be recruited at each site once they are approved by the OTP. 3\. Design: prospective, observational, multi-center, longitudinal study of outcomes and resource utilization associated with OTP. Estimates of obesity and comorbidities' impact will be obtained from the outpatient medical office for the COEs. Medical charts, databases and medical/pharmacy claims will be the source of information. Surveys on quality of life, productivity, and patient satisfaction will be administered directly to patients. Database claim information will be obtained in future and is not a part of current IRB application. 4: Procedures: After obtaining informed consent, patients will be administered surveys at baseline, as well as at follow-up visits. Additional data will be obtained via patient charts, databases, and medical/pharmacy claims.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
165

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2010

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 14, 2010

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

May 15, 2018

Status Verified

May 1, 2018

Enrollment Period

4.2 years

First QC Date

July 13, 2010

Last Update Submit

May 9, 2018

Conditions

Keywords

bariatric surgeryobesityoutcomes

Outcome Measures

Primary Outcomes (2)

  • Weight loss

    change in weight from baseline

    0, 6, 12, and 24 months

  • Body mass index (BMI)

    Change in body mass index (BMI) from baseline

    0, 6, 12, and 24 months

Secondary Outcomes (6)

  • ecomonic outcomes

    0, 6, 12, and 24 months

  • Systolic blood pressure

    0, 6, 12, and 24 months

  • Diastolic blood pressure

    0, 6, 12, and 24 months

  • Medication use

    0, 6, 12, and 24 months

  • quality of life

    0, 6, 12, and 24 months

  • +1 more secondary outcomes

Other Outcomes (1)

  • Surgery-related adverse events

    24 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

200 obese patients with Mississippi State Employee Insurance who undergo bariatric surgery as part of Obesity Treatment Program

You may qualify if:

  • Eligible bariatric surgical candidates who are enrolled in the Mississippi SSELHI Plan (100 candidates enrolled per year). The Plan's criteria includes, but is not limited to
  • enrollment in the plan for at least 12 consecutive months prior to September 1, 2009
  • completion of the HealthQuotient health risk assessment through the Plan's wellness and health promotion program
  • a Body Mass Index (BMI) of \>40 kg/m2, or a BMI \>35 kg/m2 with two or more co-morbidities such as diabetes, hypertension, sleep apnea or asthma
  • two or more physician-supervised weight loss attempts within the last 24 months
  • consent to provide personal and medical information to the Plan

You may not qualify if:

  • Any patient who does not meet criteria above or who declines to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Central Mississippi Medical Center Comprehensive Weight Management Program

Jackson, Mississippi, 39204, United States

Location

Oxford Bariatric

Oxford, Mississippi, 28677, United States

Location

Oxford Surgical & Bariatric Clinic,LLC.

Oxford, Mississippi, 38677, United States

Location

South Mississippi Surgical Weight Loss Center

Pascagoula, Mississippi, 39567, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Katie S McClendon, Pharm.D.

    University of Mississippi Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

July 13, 2010

First Posted

July 14, 2010

Study Start

April 1, 2010

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

May 15, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations